FDA Inspection 1074092 — TTY BioPharm Company Ltd (Chungli Factory)
The FDA completed an inspection of TTY BioPharm Company Ltd (Chungli Factory) on Nov 16, 2018 in Taoyuan. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Nov 16, 2018
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Taoyuan (Taiwan)